SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-322047
Filing Date
2018-11-08
Accepted
2018-11-08 09:15:01
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d632886d10q.htm 10-Q 832648
2 EX-31.1 d632886dex311.htm EX-31.1 8362
3 EX-31.2 d632886dex312.htm EX-31.2 8269
4 EX-32.1 d632886dex321.htm EX-32.1 6082
  Complete submission text file 0001193125-18-322047.txt   4410447

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snna-20180930.xml EX-101.INS 595443
6 XBRL TAXONOMY EXTENSION SCHEMA snna-20180930.xsd EX-101.SCH 52015
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snna-20180930_cal.xml EX-101.CAL 55408
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snna-20180930_def.xml EX-101.DEF 244292
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snna-20180930_lab.xml EX-101.LAB 469441
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snna-20180930_pre.xml EX-101.PRE 353343
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38155 | Film No.: 181168426
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1